GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+28.77%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$242M
AUM Growth
+$242M
Cap. Flow
+$13.6M
Cap. Flow %
5.64%
Top 10 Hldgs %
44.42%
Holding
91
New
17
Increased
15
Reduced
8
Closed
40

Top Buys

1
WMGI
Wright Medical Group Inc
WMGI
$12.1M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
$10.5M
3
SGEN
Seagen Inc. Common Stock
SGEN
$10.1M
4
PACB icon
Pacific Biosciences
PACB
$9.85M
5
SAGE
Sage Therapeutics
SAGE
$9.28M

Top Sells

1
FPRX
Five Prime Therapeutics, Inc.
FPRX
$16.6M
2
AGN
Allergan plc
AGN
$10.2M
3
GILD icon
Gilead Sciences
GILD
$6.87M
4
CELG
Celgene Corp
CELG
$6.49M
5
AVDL
Avadel Pharmaceuticals
AVDL
$5.71M

Sector Composition

1 Healthcare 90.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ZGNX
51
DELISTED
Zogenix, Inc.
ZGNX
– –
-370,000
Closed -$5M
UNIS
52
DELISTED
Unilife Corporation
UNIS
– –
-350,000
Closed -$343K
HTWR
53
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-90,000
Closed -$4.71M
RLYP
54
DELISTED
RELYPSA INC COM
RLYP
– –
-120,000
Closed -$2.22M
AEGR
55
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
– –
-250,000
Closed -$3.4M
HZNP
56
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-275,000
Closed -$5.45M
GNCA
57
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-220,000
Closed -$1.51M
ONCE
58
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-10,000
Closed -$417K
FOMX
59
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-150,000
Closed -$1.1M
AGN
60
DELISTED
Allergan plc
AGN
– –
-37,500
Closed -$10.2M
ACHC icon
61
Acadia Healthcare
ACHC
$2.15B
– –
-40,000
Closed -$1.32M
ASND icon
62
Ascendis Pharma
ASND
$12.1B
– –
-97,135
Closed -$1.72M
ATRA icon
63
Atara Biotherapeutics
ATRA
$88.7M
– –
-100,000
Closed -$3.14M
AVDL
64
Avadel Pharmaceuticals
AVDL
$1.42B
– –
-350,000
Closed -$5.71M
BCRX icon
65
BioCryst Pharmaceuticals
BCRX
$1.74B
– –
-225,000
Closed -$2.57M
BMY icon
66
Bristol-Myers Squibb
BMY
$96.7B
– –
0
– –
CLLS
67
Cellectis
CLLS
$260M
– –
-75,000
Closed -$1.98M
CYH icon
68
Community Health Systems
CYH
$392M
– –
-120,000
Closed -$5.13M
EW icon
69
Edwards Lifesciences
EW
$47.7B
– –
-40,000
Closed -$5.69M
FATE icon
70
Fate Therapeutics
FATE
$115M
– –
-89,231
Closed -$476K
FOLD icon
71
Amicus Therapeutics
FOLD
$2.42B
– –
0
– –
GILD icon
72
Gilead Sciences
GILD
$140B
– –
-70,000
Closed -$6.87M
HCA icon
73
HCA Healthcare
HCA
$95.4B
– –
-50,000
Closed -$3.87M
HRTX icon
74
Heron Therapeutics
HRTX
$204M
– –
0
– –
IOVA icon
75
Iovance Biotherapeutics
IOVA
$800M
– –
-300,000
Closed -$1.73M
1 2
3
4